Kiromic BioPharma (KRBP) Earnings Date, Estimates & Call Transcripts → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free KRBP Stock Alerts $3.08 +0.32 (+11.59%) (As of 05/16/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Earnings SummaryLatest Earnings DateMay. 10EstimatedActual EPS (May. 10) -$1.00 Missed By -$1.00 Get Kiromic BioPharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for KRBP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueKRBP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.KRBP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… KRBP Earnings Date and InformationKiromic BioPharma last posted its earnings results on May 10th, 2024. The reported ($1.00) EPS for the quarter. Kiromic BioPharma has generated ($9.90) earnings per share over the last year (($9.90) diluted earnings per share). Read More Kiromic BioPharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript5/10/2024Q1 2024-($1.00)($1.00)($1.00)--3/18/2024Q4 2023-($4.16)($4.16)($4.16)--11/14/2023Q3 2023-($1.52)($1.52)($1.52)--8/14/2023Q2 2023-($1.54)($1.54)$0.14--5/15/2023Q1 2023-($6.17)($6.17)($6.17)--11/14/2022Q3 2022($16.80)($15.90)+$0.90($0.31)-- Get the Latest News and Ratings for KRBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter. 8/12/2022Q2 2022($12.30)($16.20)($3.90)($0.54)--5/13/2022Q1 2022($8.70)($14.40)($5.70)($0.48)--4/8/2022Q4 2021-$23.70+$23.70$0.82--3/11/2022Q3 2021-($12.00)($12.00)($0.40)--8/13/2021Q2 2021-($20.40)($20.40)($0.68)-- Kiromic BioPharma Earnings - Frequently Asked Questions When did Kiromic BioPharma announce their last quarterly earnings? Kiromic BioPharma (NASDAQ:KRBP) last announced its quarterly earning data on Friday, May 10, 2024. Learn more on KRBP's earnings history. How much profit does Kiromic BioPharma generate each year? Kiromic BioPharma (NASDAQ:KRBP) has a recorded net income of -$20.95 million. KRBP has generated -$9.90 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: FNCH Earnings Date ALBT Earnings Date ELOX Earnings Date TCON Earnings Date GMDAQ Earnings Date WINT Earnings Date FRTX Earnings Date NSTGQ Earnings Date PALI Earnings Date TTNP Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:KRBP) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe Exchange[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiromic BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
